loading
Description
The gDNA Cocktail V Reference Standard contains important sites of common genes, involving 12 gene CNV sites such as EGFR/BRAF/KRAS/PIK3CA/EML4-ALK/CCDC6-RET/ERBB2, covering multiple variation types such as SNP Del Translocation CNV, with a variation frequency of 3%, and dPCR calibration.
Features
1. The samples are derived from clinically isolated cell lines, which are very close to the characteristics of clinical patients;
2. Covers a variety of cancer-related mutation sites: lung cancer, colorectal cancer, breast cancer, gastric cancer, ovarian cancer, pancreatic cancer, etc.
3. dPCR calibration;
4. Contains important sites of common genes, involving 12 gene CNV sites
General information
Name | Panel-Ref® gDNA Cocktail V Reference Standard |
Cat. No. | CBP90014 |
Format | gDNA |
Size | 1ug/vial * 1 vial |
Intended Use | Research Use Only |
Inventory Status | In Stock |
Buffer | Tris-EDTA |
Storage Conditions | 2-8℃ |
Expiry | 36 months from the date of manufacture |
Detailed Data
Gene | AA Change | CDS Change | Exon | Cosmic ID | Expected %AF | Chr position (GRCh37) |
EGFR | p.E746_A750delELREA | c.2235_2249del15 GGAATTAAGAGAAGC>- | 19 | COSM6223 | 3.0 | chr7:55242465_55242479 |
EGFR | p.L858R | c.2573T>G | 21 | COSM6224 | 3.0 | chr7:55259515 |
EGFR | p.T790M | c.2369C>T | 20 | COSM6240 | 3.0 | chr7:55249071 |
EGFR | p.G719S | c.2155G>A | 18 | COSM6252 | 3.0 | chr7:55241707 |
BRAF | p.V600E | c.1799T>A | 15 | COSM476 | Endogenous mutations | chr7:140453136 |
KRAS | p.G12D | c.35G>A | 2 | COSM521 | 3.0 | chr12:25398284 |
KRAS | p.Q61H | c.183A>C | 3 | COSM554 | Endogenous mutations | chr12:25380275 |
PIK3CA | p.E545K | c.1633G>A | 10 | COSM763 | 3.0 | chr3:178936091 |
PIK3CA | p.H1047R | c.3140A>G | 20 | COSM775 | Endogenous mutations | chr3:178952085 |
EML4-ALK | E13-A20 | DNA Translocation | N/A | COSF408 | 3.0 | N/A |
CCDC6-RET | E1-E12 | DNA Translocation | N/A | COSF1271 | 3.0 | N/A |
ERBB2 | CNV | Amplication | N/A | N/A | CN=4 | N/A |
Product application
1.Nucleic Acid Quantification and Quality Control
2.Gene Copy Number Variation Analysis
3.Genotyping and Mutation Detection:Used for the development and validation of various genotyping assays.
*Positive control: In assays such as ARMS-PCR, Sanger sequencing, and NGS, these standards provide clear comparisons of wild-type and mutant variants (e.g., EGFR L858R, KRAS G12D).
*Determining the limit of detection: By mixing mutant and wild-type standards at a specific ratio, the sensitivity of the assay can be determined. For example, determining whether a low-frequency mutation of 1% can be detected, which is crucial for tumor liquid biopsies.
*Allele Quantification: Used to accurately quantify the ratios of different alleles when analyzing methylation, mosaicism, and other conditions.
4.Next-Generation Sequencing
NGS processes are highly complex, and gDNA standards are central to quality control throughout the entire process.
*Library Construction Quality Control: As the starting material, gDNA standards monitor the efficiency and quality of library construction.
*Inter-Laboratory Comparison: Using the same set of standards allows for comparability of NGS data across different laboratories and platforms.
Related Products List
Name | Catalog No. | Details |
Panel-Ref® gDNA Cocktail II Reference Standard | CBP90009 | |
Panel-Ref® gDNA Cocktail III Reference Standard | CBP90010 | |
Panel-Ref® gDNA Cocktail IV Reference Standard | CBP90011 | |
Panel-Ref® gDNA Cocktail VI Reference Standard | CBP90015 | |
Panel-Ref® gDNA Cocktail Ⅶ Reference Standard | CBP90016 | |
Panel-Ref® gDNA Cocktail VIII Reference Standard | CBP90020 | |
Panel-Ref® gDNA Cocktail I Reference Standard | CBP90049 |
Description
The gDNA Cocktail V Reference Standard contains important sites of common genes, involving 12 gene CNV sites such as EGFR/BRAF/KRAS/PIK3CA/EML4-ALK/CCDC6-RET/ERBB2, covering multiple variation types such as SNP Del Translocation CNV, with a variation frequency of 3%, and dPCR calibration.
Features
1. The samples are derived from clinically isolated cell lines, which are very close to the characteristics of clinical patients;
2. Covers a variety of cancer-related mutation sites: lung cancer, colorectal cancer, breast cancer, gastric cancer, ovarian cancer, pancreatic cancer, etc.
3. dPCR calibration;
4. Contains important sites of common genes, involving 12 gene CNV sites
General information
Name | Panel-Ref® gDNA Cocktail V Reference Standard |
Cat. No. | CBP90014 |
Format | gDNA |
Size | 1ug/vial * 1 vial |
Intended Use | Research Use Only |
Inventory Status | In Stock |
Buffer | Tris-EDTA |
Storage Conditions | 2-8℃ |
Expiry | 36 months from the date of manufacture |
Detailed Data
Gene | AA Change | CDS Change | Exon | Cosmic ID | Expected %AF | Chr position (GRCh37) |
EGFR | p.E746_A750delELREA | c.2235_2249del15 GGAATTAAGAGAAGC>- | 19 | COSM6223 | 3.0 | chr7:55242465_55242479 |
EGFR | p.L858R | c.2573T>G | 21 | COSM6224 | 3.0 | chr7:55259515 |
EGFR | p.T790M | c.2369C>T | 20 | COSM6240 | 3.0 | chr7:55249071 |
EGFR | p.G719S | c.2155G>A | 18 | COSM6252 | 3.0 | chr7:55241707 |
BRAF | p.V600E | c.1799T>A | 15 | COSM476 | Endogenous mutations | chr7:140453136 |
KRAS | p.G12D | c.35G>A | 2 | COSM521 | 3.0 | chr12:25398284 |
KRAS | p.Q61H | c.183A>C | 3 | COSM554 | Endogenous mutations | chr12:25380275 |
PIK3CA | p.E545K | c.1633G>A | 10 | COSM763 | 3.0 | chr3:178936091 |
PIK3CA | p.H1047R | c.3140A>G | 20 | COSM775 | Endogenous mutations | chr3:178952085 |
EML4-ALK | E13-A20 | DNA Translocation | N/A | COSF408 | 3.0 | N/A |
CCDC6-RET | E1-E12 | DNA Translocation | N/A | COSF1271 | 3.0 | N/A |
ERBB2 | CNV | Amplication | N/A | N/A | CN=4 | N/A |
Product application
1.Nucleic Acid Quantification and Quality Control
2.Gene Copy Number Variation Analysis
3.Genotyping and Mutation Detection:Used for the development and validation of various genotyping assays.
*Positive control: In assays such as ARMS-PCR, Sanger sequencing, and NGS, these standards provide clear comparisons of wild-type and mutant variants (e.g., EGFR L858R, KRAS G12D).
*Determining the limit of detection: By mixing mutant and wild-type standards at a specific ratio, the sensitivity of the assay can be determined. For example, determining whether a low-frequency mutation of 1% can be detected, which is crucial for tumor liquid biopsies.
*Allele Quantification: Used to accurately quantify the ratios of different alleles when analyzing methylation, mosaicism, and other conditions.
4.Next-Generation Sequencing
NGS processes are highly complex, and gDNA standards are central to quality control throughout the entire process.
*Library Construction Quality Control: As the starting material, gDNA standards monitor the efficiency and quality of library construction.
*Inter-Laboratory Comparison: Using the same set of standards allows for comparability of NGS data across different laboratories and platforms.
Related Products List
Name | Catalog No. | Details |
Panel-Ref® gDNA Cocktail II Reference Standard | CBP90009 | |
Panel-Ref® gDNA Cocktail III Reference Standard | CBP90010 | |
Panel-Ref® gDNA Cocktail IV Reference Standard | CBP90011 | |
Panel-Ref® gDNA Cocktail VI Reference Standard | CBP90015 | |
Panel-Ref® gDNA Cocktail Ⅶ Reference Standard | CBP90016 | |
Panel-Ref® gDNA Cocktail VIII Reference Standard | CBP90020 | |
Panel-Ref® gDNA Cocktail I Reference Standard | CBP90049 |
Features
1. The samples are derived from clinically isolated cell lines, which are very close to the characteristics of clinical patients;
2. Covers a variety of cancer-related mutation sites: lung cancer, colorectal cancer, breast cancer, gastric cancer, ovarian cancer, pancreatic cancer, etc.
3. dPCR calibration;
4. Contains important sites of common genes, involving 12 gene CNV sites
Features
1. The samples are derived from clinically isolated cell lines, which are very close to the characteristics of clinical patients;
2. Covers a variety of cancer-related mutation sites: lung cancer, colorectal cancer, breast cancer, gastric cancer, ovarian cancer, pancreatic cancer, etc.
3. dPCR calibration;
4. Contains important sites of common genes, involving 12 gene CNV sites
General information
Name | Panel-Ref® gDNA Cocktail V Reference Standard |
Cat. No. | CBP90014 |
Format | gDNA |
Size | 1ug/vial * 1 vial |
Intended Use | Research Use Only |
Inventory Status | In Stock |
Buffer | Tris-EDTA |
Storage Conditions | 2-8℃ |
Expiry | 36 months from the date of manufacture |
General information
Name | Panel-Ref® gDNA Cocktail V Reference Standard |
Cat. No. | CBP90014 |
Format | gDNA |
Size | 1ug/vial * 1 vial |
Intended Use | Research Use Only |
Inventory Status | In Stock |
Buffer | Tris-EDTA |
Storage Conditions | 2-8℃ |
Expiry | 36 months from the date of manufacture |
Detailed Data
Gene | AA Change | CDS Change | Exon | Cosmic ID | Expected %AF | Chr position (GRCh37) |
EGFR | p.E746_A750delELREA | c.2235_2249del15 GGAATTAAGAGAAGC>- | 19 | COSM6223 | 3.0 | chr7:55242465_55242479 |
EGFR | p.L858R | c.2573T>G | 21 | COSM6224 | 3.0 | chr7:55259515 |
EGFR | p.T790M | c.2369C>T | 20 | COSM6240 | 3.0 | chr7:55249071 |
EGFR | p.G719S | c.2155G>A | 18 | COSM6252 | 3.0 | chr7:55241707 |
BRAF | p.V600E | c.1799T>A | 15 | COSM476 | Endogenous mutations | chr7:140453136 |
KRAS | p.G12D | c.35G>A | 2 | COSM521 | 3.0 | chr12:25398284 |
KRAS | p.Q61H | c.183A>C | 3 | COSM554 | Endogenous mutations | chr12:25380275 |
PIK3CA | p.E545K | c.1633G>A | 10 | COSM763 | 3.0 | chr3:178936091 |
PIK3CA | p.H1047R | c.3140A>G | 20 | COSM775 | Endogenous mutations | chr3:178952085 |
EML4-ALK | E13-A20 | DNA Translocation | N/A | COSF408 | 3.0 | N/A |
CCDC6-RET | E1-E12 | DNA Translocation | N/A | COSF1271 | 3.0 | N/A |
ERBB2 | CNV | Amplication | N/A | N/A | CN=4 | N/A |
Detailed Data
Gene | AA Change | CDS Change | Exon | Cosmic ID | Expected %AF | Chr position (GRCh37) |
EGFR | p.E746_A750delELREA | c.2235_2249del15 GGAATTAAGAGAAGC>- | 19 | COSM6223 | 3.0 | chr7:55242465_55242479 |
EGFR | p.L858R | c.2573T>G | 21 | COSM6224 | 3.0 | chr7:55259515 |
EGFR | p.T790M | c.2369C>T | 20 | COSM6240 | 3.0 | chr7:55249071 |
EGFR | p.G719S | c.2155G>A | 18 | COSM6252 | 3.0 | chr7:55241707 |
BRAF | p.V600E | c.1799T>A | 15 | COSM476 | Endogenous mutations | chr7:140453136 |
KRAS | p.G12D | c.35G>A | 2 | COSM521 | 3.0 | chr12:25398284 |
KRAS | p.Q61H | c.183A>C | 3 | COSM554 | Endogenous mutations | chr12:25380275 |
PIK3CA | p.E545K | c.1633G>A | 10 | COSM763 | 3.0 | chr3:178936091 |
PIK3CA | p.H1047R | c.3140A>G | 20 | COSM775 | Endogenous mutations | chr3:178952085 |
EML4-ALK | E13-A20 | DNA Translocation | N/A | COSF408 | 3.0 | N/A |
CCDC6-RET | E1-E12 | DNA Translocation | N/A | COSF1271 | 3.0 | N/A |
ERBB2 | CNV | Amplication | N/A | N/A | CN=4 | N/A |
Product application
1.Nucleic Acid Quantification and Quality Control
2.Gene Copy Number Variation Analysis
3.Genotyping and Mutation Detection:Used for the development and validation of various genotyping assays.
*Positive control: In assays such as ARMS-PCR, Sanger sequencing, and NGS, these standards provide clear comparisons of wild-type and mutant variants (e.g., EGFR L858R, KRAS G12D).
*Determining the limit of detection: By mixing mutant and wild-type standards at a specific ratio, the sensitivity of the assay can be determined. For example, determining whether a low-frequency mutation of 1% can be detected, which is crucial for tumor liquid biopsies.
*Allele Quantification: Used to accurately quantify the ratios of different alleles when analyzing methylation, mosaicism, and other conditions.
4.Next-Generation Sequencing
NGS processes are highly complex, and gDNA standards are central to quality control throughout the entire process.
*Library Construction Quality Control: As the starting material, gDNA standards monitor the efficiency and quality of library construction.
*Inter-Laboratory Comparison: Using the same set of standards allows for comparability of NGS data across different laboratories and platforms.
Product application
1.Nucleic Acid Quantification and Quality Control
2.Gene Copy Number Variation Analysis
3.Genotyping and Mutation Detection:Used for the development and validation of various genotyping assays.
*Positive control: In assays such as ARMS-PCR, Sanger sequencing, and NGS, these standards provide clear comparisons of wild-type and mutant variants (e.g., EGFR L858R, KRAS G12D).
*Determining the limit of detection: By mixing mutant and wild-type standards at a specific ratio, the sensitivity of the assay can be determined. For example, determining whether a low-frequency mutation of 1% can be detected, which is crucial for tumor liquid biopsies.
*Allele Quantification: Used to accurately quantify the ratios of different alleles when analyzing methylation, mosaicism, and other conditions.
4.Next-Generation Sequencing
NGS processes are highly complex, and gDNA standards are central to quality control throughout the entire process.
*Library Construction Quality Control: As the starting material, gDNA standards monitor the efficiency and quality of library construction.
*Inter-Laboratory Comparison: Using the same set of standards allows for comparability of NGS data across different laboratories and platforms.